rs16902947
From SNPedia
Orientation | plus |
Stabilized | plus |
Make rs16902947(A;A) |
Make rs16902947(A;G) |
Make rs16902947(G;G) |
Reference | GRCh38 38.1/141 |
Chromosome | 5 |
Position | 36308995 |
is a | snp |
is | mentioned by |
dbSNP | rs16902947 |
dbSNP (classic) | rs16902947 |
ClinGen | rs16902947 |
ebi | rs16902947 |
HLI | rs16902947 |
Exac | rs16902947 |
Gnomad | rs16902947 |
Varsome | rs16902947 |
LitVar | rs16902947 |
Map | rs16902947 |
PheGenI | rs16902947 |
Biobank | rs16902947 |
1000 genomes | rs16902947 |
hgdp | rs16902947 |
ensembl | rs16902947 |
geneview | rs16902947 |
scholar | rs16902947 |
rs16902947 | |
pharmgkb | rs16902947 |
gwascentral | rs16902947 |
openSNP | rs16902947 |
23andMe | rs16902947 |
SNPshot | rs16902947 |
SNPdbe | rs16902947 |
MSV3d | rs16902947 |
GWAS Ctlg | rs16902947 |
GMAF | 0.1667 |
Max Magnitude | 0 |
? | (A;A) (A;G) (G;G) | 28 |
---|---|---|
|
GWAS snp | |
---|---|
PMID | [PMID 23151678] |
Trait | Serum tamsulosin hydrochloride concentration |
Title | Impact of four loci on serum tamsulosin hydrochloride concentration. |
Risk Allele | A |
P-val | 1E-7 |
Odds Ratio | 19.48 [12.54-26.42] unit increase |
[PMID 28787260] Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the α-adrenergic receptor antagonist.